Leef Brands Inc.
Leef Brands Inc. ICNAF Peers
See (ICNAF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ICNAF | $0.06 | N/A | 0 | N/A | N/A | N/A |
| STMH | $0.10 | +99900.00% | 125.8B | -0.05 | -$1.89 | N/A |
| THCBF | $0.02 | +2350.00% | 58.5B | -2.45 | -$0.01 | N/A |
| MKKGY | $26.67 | +1.87% | 58.4B | 18.14 | $1.47 | +2.14% |
| MKGAF | $130.00 | -4.45% | 56.5B | 17.66 | $7.36 | +1.61% |
| HLNCF | $5.42 | -1.28% | 48.8B | 25.79 | $0.21 | +2.01% |
| TKPHF | $28.03 | +6.58% | 44.1B | 59.64 | $0.47 | +4.75% |
| KHRNF | $0.01 | +79900.00% | 41.8B | -0.80 | -$0.01 | N/A |
| IPSEY | $30.45 | +3.22% | 40.3B | 25.17 | $1.21 | N/A |
| EVRRF | $0.07 | +2780.00% | 25.6B | -2.40 | -$0.03 | N/A |
Stock Comparison
ICNAF vs STMH Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, STMH has a market cap of 125.8B. Regarding current trading prices, ICNAF is priced at $0.06, while STMH trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas STMH's P/E ratio is -0.05. In terms of profitability, ICNAF's ROE is N/A, compared to STMH's ROE of -2.75%. Regarding short-term risk, ICNAF is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs THCBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, THCBF has a market cap of 58.5B. Regarding current trading prices, ICNAF is priced at $0.06, while THCBF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas THCBF's P/E ratio is -2.45. In terms of profitability, ICNAF's ROE is N/A, compared to THCBF's ROE of +0.00%. Regarding short-term risk, ICNAF and THCBF have similar daily volatility (0.00).
ICNAF vs MKKGY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MKKGY has a market cap of 58.4B. Regarding current trading prices, ICNAF is priced at $0.06, while MKKGY trades at $26.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 18.14. In terms of profitability, ICNAF's ROE is N/A, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, ICNAF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs MKGAF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MKGAF has a market cap of 56.5B. Regarding current trading prices, ICNAF is priced at $0.06, while MKGAF trades at $130.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 17.66. In terms of profitability, ICNAF's ROE is N/A, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ICNAF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HLNCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLNCF has a market cap of 48.8B. Regarding current trading prices, ICNAF is priced at $0.06, while HLNCF trades at $5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 25.79. In terms of profitability, ICNAF's ROE is N/A, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ICNAF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TKPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TKPHF has a market cap of 44.1B. Regarding current trading prices, ICNAF is priced at $0.06, while TKPHF trades at $28.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 59.64. In terms of profitability, ICNAF's ROE is N/A, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, ICNAF and TKPHF have similar daily volatility (0.00).
ICNAF vs KHRNF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KHRNF has a market cap of 41.8B. Regarding current trading prices, ICNAF is priced at $0.06, while KHRNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KHRNF's P/E ratio is -0.80. In terms of profitability, ICNAF's ROE is N/A, compared to KHRNF's ROE of -0.69%. Regarding short-term risk, ICNAF is less volatile compared to KHRNF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs IPSEY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, IPSEY has a market cap of 40.3B. Regarding current trading prices, ICNAF is priced at $0.06, while IPSEY trades at $30.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 25.17. In terms of profitability, ICNAF's ROE is N/A, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, ICNAF and IPSEY have similar daily volatility (0.00).
ICNAF vs EVRRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, EVRRF has a market cap of 25.6B. Regarding current trading prices, ICNAF is priced at $0.06, while EVRRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas EVRRF's P/E ratio is -2.40. In terms of profitability, ICNAF's ROE is N/A, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, ICNAF is less volatile compared to EVRRF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SDZNY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SDZNY has a market cap of 22.4B. Regarding current trading prices, ICNAF is priced at $0.06, while SDZNY trades at $52.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is -2600.00. In terms of profitability, ICNAF's ROE is N/A, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SRUTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SRUTF has a market cap of 19.7B. Regarding current trading prices, ICNAF is priced at $0.06, while SRUTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SRUTF's P/E ratio is -0.09. In terms of profitability, ICNAF's ROE is N/A, compared to SRUTF's ROE of +18.75%. Regarding short-term risk, ICNAF is less volatile compared to SRUTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TEVJF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TEVJF has a market cap of 17.8B. Regarding current trading prices, ICNAF is priced at $0.06, while TEVJF trades at $15.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is -13.53. In terms of profitability, ICNAF's ROE is N/A, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, ICNAF and TEVJF have similar daily volatility (0.00).
ICNAF vs ESALY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, ICNAF is priced at $0.06, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, ICNAF's ROE is N/A, compared to ESALY's ROE of +0.06%. Regarding short-term risk, ICNAF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SGIOY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SGIOY has a market cap of 14.3B. Regarding current trading prices, ICNAF is priced at $0.06, while SGIOY trades at $8.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 12.02. In terms of profitability, ICNAF's ROE is N/A, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, ICNAF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SGIOF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SGIOF has a market cap of 12.9B. Regarding current trading prices, ICNAF is priced at $0.06, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 10.94. In terms of profitability, ICNAF's ROE is N/A, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, ICNAF and SGIOF have similar daily volatility (0.00).
ICNAF vs IPSEF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, IPSEF has a market cap of 10.4B. Regarding current trading prices, ICNAF is priced at $0.06, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 26.17. In terms of profitability, ICNAF's ROE is N/A, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, ICNAF is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs BIOVF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BIOVF has a market cap of 9.3B. Regarding current trading prices, ICNAF is priced at $0.06, while BIOVF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 22.50. In terms of profitability, ICNAF's ROE is N/A, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, ICNAF and BIOVF have similar daily volatility (0.00).
ICNAF vs NOBDF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NOBDF has a market cap of 8.5B. Regarding current trading prices, ICNAF is priced at $0.06, while NOBDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NOBDF's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to NOBDF's ROE of -0.54%. Regarding short-term risk, ICNAF is less volatile compared to NOBDF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SFOSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SFOSF has a market cap of 8.5B. Regarding current trading prices, ICNAF is priced at $0.06, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, ICNAF's ROE is N/A, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, ICNAF and SFOSF have similar daily volatility (0.00).
ICNAF vs ESAIY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ESAIY has a market cap of 8.1B. Regarding current trading prices, ICNAF is priced at $0.06, while ESAIY trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 25.18. In terms of profitability, ICNAF's ROE is N/A, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, ICNAF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs ESALF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ESALF has a market cap of 7.8B. Regarding current trading prices, ICNAF is priced at $0.06, while ESALF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 24.12. In terms of profitability, ICNAF's ROE is N/A, compared to ESALF's ROE of +0.03%. Regarding short-term risk, ICNAF and ESALF have similar daily volatility (0.00).
ICNAF vs GZPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GZPHF has a market cap of 6.4B. Regarding current trading prices, ICNAF is priced at $0.06, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, ICNAF's ROE is N/A, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, ICNAF and GZPHF have similar daily volatility (0.00).
ICNAF vs HKMPY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HKMPY has a market cap of 6.3B. Regarding current trading prices, ICNAF is priced at $0.06, while HKMPY trades at $56.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 17.67. In terms of profitability, ICNAF's ROE is N/A, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ICNAF and HKMPY have similar daily volatility (0.00).
ICNAF vs HKMPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HKMPF has a market cap of 5.9B. Regarding current trading prices, ICNAF is priced at $0.06, while HKMPF trades at $26.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 16.50. In terms of profitability, ICNAF's ROE is N/A, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ICNAF and HKMPF have similar daily volatility (0.00).
ICNAF vs HLUBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLUBF has a market cap of 5.2B. Regarding current trading prices, ICNAF is priced at $0.06, while HLUBF trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 11.31. In terms of profitability, ICNAF's ROE is N/A, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, ICNAF and HLUBF have similar daily volatility (0.00).
ICNAF vs HLBBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLBBF has a market cap of 4.7B. Regarding current trading prices, ICNAF is priced at $0.06, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 12.71. In terms of profitability, ICNAF's ROE is N/A, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, ICNAF and HLBBF have similar daily volatility (0.00).
ICNAF vs LVZPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LVZPF has a market cap of 4.2B. Regarding current trading prices, ICNAF is priced at $0.06, while LVZPF trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 12.37. In terms of profitability, ICNAF's ROE is N/A, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ICNAF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs APNHY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, APNHY has a market cap of 3.1B. Regarding current trading prices, ICNAF is priced at $0.06, while APNHY trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is 12.26. In terms of profitability, ICNAF's ROE is N/A, compared to APNHY's ROE of +0.05%. Regarding short-term risk, ICNAF and APNHY have similar daily volatility (0.00).
ICNAF vs INVVY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, ICNAF is priced at $0.06, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ICNAF's ROE is N/A, compared to INVVY's ROE of -0.01%. Regarding short-term risk, ICNAF and INVVY have similar daily volatility (0.00).
ICNAF vs IZQVF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, ICNAF is priced at $0.06, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ICNAF's ROE is N/A, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, ICNAF and IZQVF have similar daily volatility (0.00).
ICNAF vs HYPMY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HYPMY has a market cap of 2.9B. Regarding current trading prices, ICNAF is priced at $0.06, while HYPMY trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 20.68. In terms of profitability, ICNAF's ROE is N/A, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, ICNAF and HYPMY have similar daily volatility (0.00).
ICNAF vs WIBFF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, WIBFF has a market cap of 2.9B. Regarding current trading prices, ICNAF is priced at $0.06, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, ICNAF's ROE is N/A, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs APNHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, APNHF has a market cap of 2.8B. Regarding current trading prices, ICNAF is priced at $0.06, while APNHF trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is 10.44. In terms of profitability, ICNAF's ROE is N/A, compared to APNHF's ROE of +0.04%. Regarding short-term risk, ICNAF and APNHF have similar daily volatility (0.00).
ICNAF vs ULIHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ULIHF has a market cap of 2.5B. Regarding current trading prices, ICNAF is priced at $0.06, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, ICNAF's ROE is N/A, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, ICNAF is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HMDCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, ICNAF is priced at $0.06, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is -58.00. In terms of profitability, ICNAF's ROE is N/A, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, ICNAF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SHEZF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SHEZF has a market cap of 2.5B. Regarding current trading prices, ICNAF is priced at $0.06, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, ICNAF's ROE is N/A, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, ICNAF and SHEZF have similar daily volatility (0.00).
ICNAF vs HTSUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HTSUF has a market cap of 2.4B. Regarding current trading prices, ICNAF is priced at $0.06, while HTSUF trades at $33.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.10. In terms of profitability, ICNAF's ROE is N/A, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, ICNAF and HTSUF have similar daily volatility (0.00).
ICNAF vs DNPUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, DNPUF has a market cap of 2.3B. Regarding current trading prices, ICNAF is priced at $0.06, while DNPUF trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 14.15. In terms of profitability, ICNAF's ROE is N/A, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, ICNAF and DNPUF have similar daily volatility (0.00).
ICNAF vs CHSYF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CHSYF has a market cap of 2.2B. Regarding current trading prices, ICNAF is priced at $0.06, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, ICNAF's ROE is N/A, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, ICNAF and CHSYF have similar daily volatility (0.00).
ICNAF vs TSMRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, ICNAF is priced at $0.06, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, ICNAF's ROE is N/A, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, ICNAF and TSMRF have similar daily volatility (0.00).
ICNAF vs DMPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, ICNAF is priced at $0.06, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 18.15. In terms of profitability, ICNAF's ROE is N/A, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, ICNAF and DMPHF have similar daily volatility (0.00).
ICNAF vs LBTSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LBTSF has a market cap of 2.1B. Regarding current trading prices, ICNAF is priced at $0.06, while LBTSF trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 162.50. In terms of profitability, ICNAF's ROE is N/A, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, ICNAF and LBTSF have similar daily volatility (0.00).
ICNAF vs LJUIF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, ICNAF is priced at $0.06, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, ICNAF's ROE is N/A, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, ICNAF and LJUIF have similar daily volatility (0.00).
ICNAF vs NPNKF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, ICNAF is priced at $0.06, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 7.61. In terms of profitability, ICNAF's ROE is N/A, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, ICNAF and NPNKF have similar daily volatility (0.00).
ICNAF vs NPPNY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NPPNY has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while NPPNY trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 7.26. In terms of profitability, ICNAF's ROE is N/A, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, ICNAF and NPPNY have similar daily volatility (0.00).
ICNAF vs EVOTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, EVOTF has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while EVOTF trades at $9.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -8.38. In terms of profitability, ICNAF's ROE is N/A, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, ICNAF and EVOTF have similar daily volatility (0.00).
ICNAF vs SMDPY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SMDPY has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 9.76. In terms of profitability, ICNAF's ROE is N/A, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, ICNAF and SMDPY have similar daily volatility (0.00).
ICNAF vs MITPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, ICNAF's ROE is N/A, compared to MITPF's ROE of +4.92%. Regarding short-term risk, ICNAF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs YIHCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, YIHCF has a market cap of 1.6B. Regarding current trading prices, ICNAF is priced at $0.06, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ICNAF's ROE is N/A, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, ICNAF and YIHCF have similar daily volatility (0.00).
ICNAF vs KARBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, ICNAF is priced at $0.06, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ICNAF's ROE is N/A, compared to KARBF's ROE of N/A. Regarding short-term risk, ICNAF and KARBF have similar daily volatility (0.00).
ICNAF vs ARSUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ARSUF has a market cap of 1.5B. Regarding current trading prices, ICNAF is priced at $0.06, while ARSUF trades at $20.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.78. In terms of profitability, ICNAF's ROE is N/A, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, ICNAF is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TWAPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 9.56. In terms of profitability, ICNAF's ROE is N/A, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, ICNAF and TWAPF have similar daily volatility (0.00).
ICNAF vs GTBIF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GTBIF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while GTBIF trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 24.91. In terms of profitability, ICNAF's ROE is N/A, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, ICNAF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CHIZF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CHIZF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while CHIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is 12.00. In terms of profitability, ICNAF's ROE is N/A, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, ICNAF and CHIZF have similar daily volatility (0.00).
ICNAF vs CASBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CASBF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while CASBF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -17.81. In terms of profitability, ICNAF's ROE is N/A, compared to CASBF's ROE of -0.14%. Regarding short-term risk, ICNAF and CASBF have similar daily volatility (0.00).
ICNAF vs KSPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KSPHF has a market cap of 1.2B. Regarding current trading prices, ICNAF is priced at $0.06, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 14.43. In terms of profitability, ICNAF's ROE is N/A, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, ICNAF and KSPHF have similar daily volatility (0.00).
ICNAF vs SWGHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, ICNAF is priced at $0.06, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 16.00. In terms of profitability, ICNAF's ROE is N/A, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, ICNAF and SWGHF have similar daily volatility (0.00).
ICNAF vs GNMLF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, ICNAF is priced at $0.06, while GNMLF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 10.36. In terms of profitability, ICNAF's ROE is N/A, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, ICNAF and GNMLF have similar daily volatility (0.00).
ICNAF vs SHPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SHPHF has a market cap of 1.1B. Regarding current trading prices, ICNAF is priced at $0.06, while SHPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -4.06. In terms of profitability, ICNAF's ROE is N/A, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, ICNAF and SHPHF have similar daily volatility (0.00).
ICNAF vs KKPCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, ICNAF is priced at $0.06, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 10.46. In terms of profitability, ICNAF's ROE is N/A, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, ICNAF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs BIOGY Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BIOGY has a market cap of 884.8M. Regarding current trading prices, ICNAF is priced at $0.06, while BIOGY trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 28.07. In terms of profitability, ICNAF's ROE is N/A, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, ICNAF and BIOGY have similar daily volatility (0.00).
ICNAF vs NRXCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NRXCF has a market cap of 844.9M. Regarding current trading prices, ICNAF is priced at $0.06, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, ICNAF's ROE is N/A, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, ICNAF and NRXCF have similar daily volatility (0.00).
ICNAF vs CSWYF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, ICNAF is priced at $0.06, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, ICNAF's ROE is N/A, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, ICNAF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TCNNF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TCNNF has a market cap of 767.6M. Regarding current trading prices, ICNAF is priced at $0.06, while TCNNF trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -5.08. In terms of profitability, ICNAF's ROE is N/A, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, ICNAF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs AGYTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, AGYTF has a market cap of 757.9M. Regarding current trading prices, ICNAF is priced at $0.06, while AGYTF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -15.90. In terms of profitability, ICNAF's ROE is N/A, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, ICNAF is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs TRXPF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, ICNAF is priced at $0.06, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ICNAF's ROE is N/A, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, ICNAF and TRXPF have similar daily volatility (0.00).
ICNAF vs ABSCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ABSCF has a market cap of 682.7M. Regarding current trading prices, ICNAF is priced at $0.06, while ABSCF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -67.65. In terms of profitability, ICNAF's ROE is N/A, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, ICNAF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SWDCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SWDCF has a market cap of 679.3M. Regarding current trading prices, ICNAF is priced at $0.06, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, ICNAF's ROE is N/A, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ICNAF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs NIKA Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, NIKA has a market cap of 666.7M. Regarding current trading prices, ICNAF is priced at $0.06, while NIKA trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to NIKA's ROE of +0.39%. Regarding short-term risk, ICNAF is less volatile compared to NIKA. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CURLF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CURLF has a market cap of 666.4M. Regarding current trading prices, ICNAF is priced at $0.06, while CURLF trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -2.67. In terms of profitability, ICNAF's ROE is N/A, compared to CURLF's ROE of -0.25%. Regarding short-term risk, ICNAF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs LVTTF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LVTTF has a market cap of 661.3M. Regarding current trading prices, ICNAF is priced at $0.06, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, ICNAF's ROE is N/A, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs BOIRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BOIRF has a market cap of 622.4M. Regarding current trading prices, ICNAF is priced at $0.06, while BOIRF trades at $35.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 25.25. In terms of profitability, ICNAF's ROE is N/A, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, ICNAF and BOIRF have similar daily volatility (0.00).
ICNAF vs TRSSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, ICNAF is priced at $0.06, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ICNAF's ROE is N/A, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, ICNAF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs ELTP Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, ELTP has a market cap of 598.2M. Regarding current trading prices, ICNAF is priced at $0.06, while ELTP trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is -28.00. In terms of profitability, ICNAF's ROE is N/A, compared to ELTP's ROE of -0.36%. Regarding short-term risk, ICNAF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs MNFSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, MNFSF has a market cap of 566M. Regarding current trading prices, ICNAF is priced at $0.06, while MNFSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas MNFSF's P/E ratio is -0.08. In terms of profitability, ICNAF's ROE is N/A, compared to MNFSF's ROE of +16.59%. Regarding short-term risk, ICNAF is less volatile compared to MNFSF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CCHWF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, ICNAF is priced at $0.06, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ICNAF's ROE is N/A, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, ICNAF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs SGFEF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, SGFEF has a market cap of 508.7M. Regarding current trading prices, ICNAF is priced at $0.06, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 22.88. In terms of profitability, ICNAF's ROE is N/A, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, ICNAF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs AIHLF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, AIHLF has a market cap of 507.8M. Regarding current trading prices, ICNAF is priced at $0.06, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, ICNAF's ROE is N/A, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ICNAF is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PEXXF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, ICNAF is priced at $0.06, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ICNAF's ROE is N/A, compared to PEXXF's ROE of N/A. Regarding short-term risk, ICNAF and PEXXF have similar daily volatility (0.00).
ICNAF vs KHTRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, KHTRF has a market cap of 422.9M. Regarding current trading prices, ICNAF is priced at $0.06, while KHTRF trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is 60.63. In terms of profitability, ICNAF's ROE is N/A, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, ICNAF and KHTRF have similar daily volatility (0.00).
ICNAF vs LRDSF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LRDSF has a market cap of 378.7M. Regarding current trading prices, ICNAF is priced at $0.06, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LRDSF's P/E ratio is -0.03. In terms of profitability, ICNAF's ROE is N/A, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, ICNAF and LRDSF have similar daily volatility (0.00).
ICNAF vs CNGGF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CNGGF has a market cap of 364.1M. Regarding current trading prices, ICNAF is priced at $0.06, while CNGGF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CNGGF's P/E ratio is -0.09. In terms of profitability, ICNAF's ROE is N/A, compared to CNGGF's ROE of -1.60%. Regarding short-term risk, ICNAF and CNGGF have similar daily volatility (0.00).
ICNAF vs BHCCF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BHCCF has a market cap of 293.9M. Regarding current trading prices, ICNAF is priced at $0.06, while BHCCF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.95. In terms of profitability, ICNAF's ROE is N/A, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, ICNAF and BHCCF have similar daily volatility (0.00).
ICNAF vs GLASF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, GLASF has a market cap of 291.7M. Regarding current trading prices, ICNAF is priced at $0.06, while GLASF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -63.33. In terms of profitability, ICNAF's ROE is N/A, compared to GLASF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs BHHKF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BHHKF has a market cap of 290.1M. Regarding current trading prices, ICNAF is priced at $0.06, while BHHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BHHKF's P/E ratio is -0.01. In terms of profitability, ICNAF's ROE is N/A, compared to BHHKF's ROE of -1.94%. Regarding short-term risk, ICNAF is less volatile compared to BHHKF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PKBFF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PKBFF has a market cap of 289.4M. Regarding current trading prices, ICNAF is priced at $0.06, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, ICNAF's ROE is N/A, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ICNAF is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PSIQ Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PSIQ has a market cap of 232.4M. Regarding current trading prices, ICNAF is priced at $0.06, while PSIQ trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PSIQ's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to PSIQ's ROE of -1.73%. Regarding short-term risk, ICNAF is less volatile compared to PSIQ. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CRLBF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CRLBF has a market cap of 230.5M. Regarding current trading prices, ICNAF is priced at $0.06, while CRLBF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.16. In terms of profitability, ICNAF's ROE is N/A, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, ICNAF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs CPHRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, CPHRF has a market cap of 229.3M. Regarding current trading prices, ICNAF is priced at $0.06, while CPHRF trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 24.86. In terms of profitability, ICNAF's ROE is N/A, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, ICNAF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs VRNOF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, VRNOF has a market cap of 215.8M. Regarding current trading prices, ICNAF is priced at $0.06, while VRNOF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -0.60. In terms of profitability, ICNAF's ROE is N/A, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, ICNAF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PLNHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, ICNAF is priced at $0.06, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ICNAF's ROE is N/A, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, ICNAF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs WLDFF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, WLDFF has a market cap of 170.2M. Regarding current trading prices, ICNAF is priced at $0.06, while WLDFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas WLDFF's P/E ratio is N/A. In terms of profitability, ICNAF's ROE is N/A, compared to WLDFF's ROE of -0.19%. Regarding short-term risk, ICNAF is less volatile compared to WLDFF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs BKUH Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, BKUH has a market cap of 150.7M. Regarding current trading prices, ICNAF is priced at $0.06, while BKUH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas BKUH's P/E ratio is -50.00. In terms of profitability, ICNAF's ROE is N/A, compared to BKUH's ROE of +0.10%. Regarding short-term risk, ICNAF and BKUH have similar daily volatility (0.00).
ICNAF vs HUMDF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HUMDF has a market cap of 147.5M. Regarding current trading prices, ICNAF is priced at $0.06, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, ICNAF's ROE is N/A, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, ICNAF and HUMDF have similar daily volatility (0.00).
ICNAF vs COPHF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, ICNAF is priced at $0.06, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ICNAF's ROE is N/A, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ICNAF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs PHCUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, PHCUF has a market cap of 119.4M. Regarding current trading prices, ICNAF is priced at $0.06, while PHCUF trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 448.00. In terms of profitability, ICNAF's ROE is N/A, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, ICNAF is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs UPPR Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, UPPR has a market cap of 115.9M. Regarding current trading prices, ICNAF is priced at $0.06, while UPPR trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas UPPR's P/E ratio is -0.07. In terms of profitability, ICNAF's ROE is N/A, compared to UPPR's ROE of -0.15%. Regarding short-term risk, ICNAF is less volatile compared to UPPR. This indicates potentially lower risk in terms of short-term price fluctuations for ICNAF.
ICNAF vs HLTRF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, HLTRF has a market cap of 115.8M. Regarding current trading prices, ICNAF is priced at $0.06, while HLTRF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -6.42. In terms of profitability, ICNAF's ROE is N/A, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, ICNAF and HLTRF have similar daily volatility (0.00).
ICNAF vs LPCUF Comparison
ICNAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ICNAF stands at 0. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, ICNAF is priced at $0.06, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ICNAF currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, ICNAF's ROE is N/A, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, ICNAF and LPCUF have similar daily volatility (0.00).